Anthropometric measures of increased central and overall adiposity in association with echocardiographic left ventricular hypertrophy

Hypertension Research

Volumn 33, Issue 1, 2010, Pages 83-87

  Rodrigues, Sérgio Lamego ^a   Baldo, Marcelo Perim ^a   Sá Cunha, Roberto ^a   Angelo, Lílian Cs ^b   Pereira, Alexandre C ^b   Krieger, José Eduardo ^b   Mill, José Geraldo ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Abdominal adiposity; Body mass index; Left ventricular hypertrophy

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; FEMALE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PARAMETERS OF MEASUREMENT AND ANALYSIS; PREDICTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WAIST STATURE RATIO;

EID: 74349091932     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.188     Document Type: Article

References (44)

1. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S, the INTERHEART Investigators in Latin America. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation 2007; 115: 1067-1074. (Pubitemid 46673168)
2. Lopez A, Mathers C, Ezzati M, Jamison D, Murray C. Global Burden of Disease and Risk Factors. The World Bank and Oxford University Press: New York, NY, 2006.
3. Gaziano T. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005; 112: 3547-3553.
4. Ostlund Jr RE, Staten M, Kohrt WM, Schultz J, Malley M. The ratio of waist to hip circumference, plasma insulin level and glucose intolerance as independent predictors of the HDL cholesterol level in older adults. N Engl J Med 1990; 322: 229-234.
5. De Fronzo RA, Ferranini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
6. Eckel RH. Obesity and heart disease: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 1997; 96: 3248-3250.
7. World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report. World Health Organization: Geneva, 1997.
8. Lesser GT, Deutsch S, Markofsky J. Use of an independent measurement of body fat to evaluate overweight and underweight. Metabolism 1971; 20: 792-804.
9. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
10. Li C, Ford ES, McGuire LC, Mokdad AH. Increasing trends in waist circumference and abdominal obesity among US adults. Obesity 2007; 15: 216-224.
11. Price GM, Uauy R, Breeze E, Bulpitt CJ, Fletcher AE. Weight, shape, and mortality risk in older persons: elevated waist-hip ratio, not high body mass index, is associated with a greater risk of death. Am J Clin Nutr 2006; 84: 449-460.
12. Hsieh SD, Yoshinaga H. Waist/height ratio as a simple and useful predictor of coronary heart disease risk factors in women. Intern Med 1995; 34: 1147-1152.
13. Kahn R, Robertson R, Smith R, Eddy D. The impact of prevention on reducing the burden of CVD. Circulation 2008; 118: 576-585.
14. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-352.
15. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-1566.
16. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90: 583-612.
17. Pires-de-Sousa AG, Pereira AC, Marquezini GF, Nascimento-Neto RM, Freitas SN, Nicolato RLC, Machado-Coelho GLL, Rodrigues SL, Mill JG, Krieger JE. Derivation and external validation of a simple prediction model for the diagnosis of type 2 Diabetes Mellitus in the Brazilian urban population. Eur J Epidemiol 2009; 24: 101-109.
18. Rodrigues SL, Angelo LC, Pereira AC, Krieger JE, Mill JG. Determinants of left ventricular mass and presence of metabolic risk factors in normotensive individuals. Int J Cardiol 2009; 135: 323-330.
19. National Institute of Health. Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults. Obes Res 1998; 6: 51S-209S.
20. Sahn DJ, De Maria A, Kisslo J, Weyman A. The Committee on M-Mode Standardization of the American Society of Echocardiography. Recommendations regarding Quantita-tion in M-Mode Echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083.
21. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57: 450-458.
22. De Simone G, Devereux RB. Gender differences in left ventricular growth. Hypertension 1995; 26: 979-983.
23. De Simone G, Kizer JR, Devereux RB. Normalization for body size and population attributable risk of left ventricular hypertrophy: The Strong Heart Study. Am J Hypertens 2005; 18: 191-196. (Pubitemid 40332548)
24. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; 1: 307-310.
25. Angelo LCS, Vieira MLC, Rodrigues SL, Morelato RL, Pereira AC, Mill AC, Krieger JE. Echocardiographic reference values in a sample of asymptomatic adult Brazilian population. Arq Bras Cardiol 2007; 89: 184-190.
26. Ilercil A, O'Grady MJ, Roman MJ, Paranicas M, Lee ET, Welty TK, Fabsitz RR, Howard BV, Devereux RB. Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity. The Strong Heart Study. J Am Soc Echocardiogr 2001; 14: 601-611.
27. Cuspidi C, Meani S, Negri F, Giudici V, Valerio C, Sala C, Zanchetti A, Mancia G. Indexation of left ventricular mass to body surface area and height to allometric power of 2.7: is the difference limited to obese hypertensives? J Hum Hypertens 2009; 23: 728-734.
28. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic curve. Radiology 1982; 143: 29-36.
29. Metz CE. Basic principles of ROC curve analysis. Semin Nucl Med 1978; 8: 283-298.
30. Altman DG, Gardner M. Diagnostics tests. In: Altman DG, Machin D, Trevor NB (eds), BMJ Book, 2nd edn. 2000, pp 105-119.
31. Finkelstein EA, Fiebelkorn IC, Wang G. State-level estimates of annual medical expenditures attributable to obesity. Obes Res 2004; 12: 18-24.
32. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005; 96: 939-949.
33. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591.
34. Devereux RB, Alderman MH. Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. Circulation 1993; 88: 1444-1455.
35. De Simone G, Devereux RB, Chinali L, Roman MJ, Lee ET, Resnick HE, Howard BV. Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: The Strong Heart Study. Nutr Metab Cardiovas Dis 2009; 19: 98-104.
36. Tsioufis CP, Tsiachris DL, Selima MN, Dimitriadis KS, Thomopoulos CG, Tsiliggiris DC, Gennadi AS, Syrseloudis DC, Stefanadi ES, Toutouzas KP, Kallikazaros IE, Stefanadis CI. Impact of waist circumference on cardiac phenotype in hypertensives according to gender. Obesity 2009; 17: 177-182.
37. James WP. Assessing obesity: are ethnic differences in body mass index and waist classification criteria justified? Obes Rev 2005; 6: 179-181.
38. Franzosi MG. Should we continue to use BMI as a cardiovascular risk factor? Lancet 2006; 368: 624-625.
39. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35: 83-92.
40. Cameron AJ, Welborn TA, Zimmet PZ, Dunstan DW, Owen N, Salmon J, Dalton M, Jolley D, Shaw JE. Overweight and obesity in Australia: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study. Med J Aust 2003; 178: 427-432.
41. Zhang C, Rexrode KM, Van Dam RM, Li TY, Hu FB. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality sixteen years of follow-up in US women. Circulation 2008; 117: 1658-1667.
42. Egan BM, Lu G, Greene EL. Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster. Prostagladins Leukot Essent Fatty Acids 1999; 60: 411-420.
43. Snijder MB, van Dam RM, Visser M, Seidell JC. What aspects of body fat are particularly hazardous and how do we measure them? Int J Epidemiol 2006; 35: 83-92.
44. Lavie CJ, Milani RV, Ventura HO, Cardenas GA, Mehra MR, Messerli FH. Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction. Am J Cardiol 2007; 100: 1460-1464.